Clinical Trial Update: Morphine for Dyspnea in Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating morphine for dyspnea in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Morphine (morphine)

Snippet

Sponsor: Medical University of Gdansk | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Phase 3 | Status: UNKNOWN